2057-7540

Cardiac Failure Review

Radcliffe Medical Media Ltd

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 115 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact115 DOIs
2

Add license metadata to 71 records

License metadata tells indexers and readers how each article may be reused.

Medium impact71 DOIs
3

Deposit reference lists for 57 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact57 DOIs

DOIs for this ISSN

Showing the top 5 of 215 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Left Ventricular Assist Devices in the Management of Heart F… (10.15420/cfr.2015.01.01.25)
References ORCID License
109.68 28
2 The Bi-directional Impact of Two Chronic Illnesses: Heart Fa… (10.15420/cfr.2015.01.01.8)
References ORCID License
108.54 27
3 Pulmonary Oedema—Therapeutic Targets (10.15420/cfr.2015.01.01.38)
References ORCID License
95.91 18
4 Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clin… (10.15420/cfr.2020.03)
References ORCID
85.38 50
5 Assessment for Exercise Prescription in Heart Failure (10.15420/cfr.2015.01.01.46)
References ORCID License
71.57 8
6 Management of Heart Failure in Patients Nearing the End of L… (10.15420/cfr.2015.01.01.31)
References ORCID License
67.73 7
7 Sleep-disordered Breathing in Heart Failure – Current State… (10.15420/cfr.2015.01.01.16)
References ORCID License
63.38 6
8 Cardiac Resynchronisation Therapy and Heart Failure: Persepc… (10.15420/cfr.2015.01.01.35)
References ORCID License
63.38 6
9 Right Ventricular Failure: Pathophysiology, Diagnosis and Tr… (10.15420/cfr.2019.15.2)
ORCID
54.90 156
10 Red Cell Volume Distribution Width as Another Biomarker (10.15420/cfr.2019.13.1)
Abstract ORCID
53.96 11
11 Remote Management of Heart Failure: An Overview of Telemonit… (10.15420/cfr.2019.5.3)
ORCID
52.85 129
12 Biomarkers in Routine Heart Failure Clinical Care (10.15420/cfr.2018.27.2)
ORCID
50.32 102
13 Natriuretic Peptides in Chronic Heart Failure (10.15420/cfr.2018.26.1)
ORCID
48.61 87
14 Inotropes in Acute Heart Failure: From Guidelines to Practic… (10.15420/cfr.2019.11.2)
ORCID
45.32 64
15 The Management of Heart Failure with Preserved Ejection Frac… (10.15420/cfr.2015.01.01.11)
References ORCID License
45.15 3
16 Exercise Training and Heart Failure: A Review of the Literat… (10.15420/cfr.2018.31.1)
ORCID
42.25 48
17 Heart Failure and Problems with Frailty Syndrome: Why it is… (10.15420/cfr.2018.37.1)
ORCID
42.25 48
18 High-flow Nasal Cannula Oxygenation Revisited in COVID-19 (10.15420/cfr.2020.06)
Abstract ORCID
42.25 6
19 Extracorporeal Membrane Oxygenation in Coronavirus Disease 2… (10.15420/cfr.2020.16)
Abstract ORCID
42.25 6
20 Would You Prescribe Mobile Health Apps for Heart Failure Sel… (10.15420/cfr.2019.11)
ORCID
41.80 46
21 Bidirectional Relationship Between Cancer and Heart Failure:… (10.15420/cfr.2019.1.2)
ORCID
41.57 45
22 Heart Failure and Cancer: Mechanisms of Old and New Cardioto… (10.15420/cfr.2018.32.2)
ORCID
40.84 42
23 Hospice Use Among Patients with Heart Failure (10.15420/cfr.2019.2.2)
ORCID
39.21 36
24 Temporary Mechanical Circulatory Support in Acute Heart Fail… (10.15420/cfr.2019.02)
ORCID
38.60 34
25 Artificial Intelligence, Data Sensors and Interconnectivity:… (10.15420/cfr.2019.14)
ORCID
38.60 34
26 The New Heart Failure Association Definition of Advanced Hea… (10.15420/cfr.2018.43.1)
ORCID
38.29 33
27 Focusing on Referral Rather than Selection for Advanced Hear… (10.15420/cfr.2018.35.1)
ORCID
37.96 32
28 Aortic Stenosis and Heart Failure: Disease Ascertainment and… (10.15420/cfr.2018.41.2)
ORCID
37.63 31
29 Congestion and Diuretic Resistance in Acute or Worsening Hea… (10.15420/cfr.2019.18)
ORCID
37.63 31
30 Subclinical Left Ventricular Dysfunction During Chemotherapy (10.15420/cfr.2018.25.1)
ORCID
37.28 30
31 Gaps in the Heart Failure Guidelines (10.15420/cfr.2015.01.01.50)
References ORCID License
35.78 2
32 The Limitations of Symptom-based Heart Failure Management (10.15420/cfr.2019.3.2)
ORCID
34.95 24
33 Ultrafiltration in Acute Heart Failure (10.15420/cfr.2018.29.2)
ORCID
34.51 23
34 Winter Peaks in Heart Failure: An Inevitable or Preventable… (10.15420/cfr.2018.40.2)
ORCID
34.04 22
35 Mechanisms of Myocardial Injury in Coronavirus Disease 2019 (10.15420/cfr.2020.10)
ORCID
34.04 22
36 Diet, the Gut Microbiome and Heart Failure (10.15420/cfr.2018.39.2)
ORCID
33.56 21
37 Sodium–Glucose Co-transporter 2 Inhibitors in Heart Failure:… (10.15420/cfr.2020.23)
ORCID
33.06 20
38 Telemedicine, Artificial Intelligence and Humanisation of Cl… (10.15420/cfr.2019.17)
ORCID
31.38 17
39 Neprilysin as a Biomarker: Challenges and Opportunities (10.15420/cfr.2019.21)
ORCID
31.38 17
40 Why is Iron Deficiency Recognised as an Important Comorbidit… (10.15420/cfr.2019.9.2)
ORCID
30.10 15
41 Choosing Between Left Ventricular Assist Devices and Biventr… (10.15420/cfr.2018.23.2)
ORCID
28.65 13
42 The Use of App-based Follow-up of Cardiac Implantable Electr… (10.15420/cfr.2019.13)
ORCID
28.65 13
43 Effects of Exercise Training on Cardiac Function in Heart Fa… (10.15420/cfr.2020.17)
ORCID
28.65 13
44 Biomarkers to Improve Decision-making in Acute Heart Failure (10.15420/cfr.2023.08)
ORCID
28.65 13
45 Treatment of Heart Failure with Sodium-Glucose Cotransporter… (10.15420/cfr.2018.44.1)
ORCID
26.98 11
46 Pulmonary Hypertension in Heart Failure Patients (10.15420/cfr.2019.09)
ORCID
26.98 11
47 Red Blood Cell Distribution Width as a Biomarker of Red Cell… (10.15420/cfr.2024.17)
Abstract
26.98 11
48 Suppression of Tumourigenicity 2 in Heart Failure With Prese… (10.15420/cfr.2019.10)
ORCID
26.03 10
49 Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibi… (10.15420/cfr.2019.8.2)
ORCID
26.03 10
50 The Therapy and Management of Heart Failure with Preserved E… (10.15420/cfr.2023.13)
ORCID
26.03 10